Evidence map›Paper›PMID 32822127›Full record

ArticleInternational braz j urol : official journal of the Brazilian Society of Urology

Does mpMRI guidance improve HIFU partial gland ablation compared to conventional ultrasound guidance? Early functional outcomes and complications from a single center.

Arjun Sivaraman, Giancarlo Marra, Armando Stabile, Annick Mombet, Petr Macek, Camille Lanz, Nathalie Cathala, Marco Moschini, Arie Carneiro, Rafael Sanchez-Salas and 1 more

Open access · diamondAbstract readComparative Study
In one paragraph

Article in International braz j urol : official journal of the Brazilian Society of Urology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Available evidence on HIFU for focal treatment of prostate cancer: a systematic review.International braz j urol : official journal of the Brazilian Society of Urology
    Pooled it
  2. Review
  3. Article
  4. Outcomes of ablative therapy and radical treatment for prostate cancer: a systematic review and meta-analysis.International braz j urol : official journal of the Brazilian Society of Urology · 2024
    Review
  5. Article
  6. Article
  7. The new impact factor of International Brazilian Journal of Urology is 1.342. Where can we get?International braz j urol : official journal of the Brazilian Society of Urology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Arjun SivaramanDepartment of Urology, L'Institut Mutualiste Montsouris, Université Paris Descartes, Paris, France.
Giancarlo MarraDepartment of Urology, L'Institut Mutualiste Montsouris, Université Paris Descartes, Paris, France.
Armando StabileDepartment of Urology, L'Institut Mutualiste Montsouris, Université Paris Descartes, Paris, France.
Annick MombetDepartment of Urology, L'Institut Mutualiste Montsouris, Université Paris Descartes, Paris, France.
Petr MacekDepartment of Urology, L'Institut Mutualiste Montsouris, Université Paris Descartes, Paris, France.
Camille LanzDepartment of Urology, L'Institut Mutualiste Montsouris, Université Paris Descartes, Paris, France.
Nathalie CathalaDepartment of Urology, L'Institut Mutualiste Montsouris, Université Paris Descartes, Paris, France.
Marco MoschiniDepartment of Urology, L'Institut Mutualiste Montsouris, Université Paris Descartes, Paris, France.
Arie CarneiroDepartment of Urology, L'Institut Mutualiste Montsouris, Université Paris Descartes, Paris, France.
Rafael Sanchez-SalasDepartment of Urology, L'Institut Mutualiste Montsouris, Université Paris Descartes, Paris, France.
Xavier CathelineauDepartment of Urology, L'Institut Mutualiste Montsouris, Université Paris Descartes, Paris, France.
Délégation Paris 5 · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFocal therapy (FT) for localized prostate cancer (PCa) treatment is raising interest. New technological mpMRI-US guided FT devices have never been compared with the previous generation of ultrasound-only guided devices. MATERIALS AND

methodsWe retrospectively analyzed prospectively recorded data of men undergoing FT for localized low- or intermediate-risk PCa with US- (Ablatherm®-2009 to 2014) or mpMRI-US (Focal One®-from 2014) guided HIFU. Follow-up visits and data were collected using internationally validated questionnaires at 1, 2, 3, 6 and 12 months.

resultsWe included n=88 US-guided FT HIFU and n=52 mpMRI-US guided FT HIFU respectively. No major baseline differences were present except higher rates of Gleason 3+4 for the mpMRI-US group. No major differences were present in hospital stay (p=0.1), catheterization time (p=0.5) and complications (p=0.2) although these tended to be lower in the mpMRI-US group (6.8% versus 13.2% US FT group). At 3 months mpMRI-US guided HIFU had significantly lower urine leak (5.1% vs. 15.9%, p=0.04) and a lower drop in IIEF scores (2 vs. 4.2, p=0.07). Of those undergoing 12-months control biopsy in the mpMRI-US-guided HIFU group, 26% had residual cancer in the treated lobe.

conclusionHIFU FT guided by MRI-US fusion may allow improved functional outcomes and fewer complications compared to US- guided HIFU FT alone. Further analysis is needed to confirm benefits of mpMRI implementation at a longer follow-up and on a larger cohort of patients.

Indexed as

Multiparametric Magnetic Resonance ImagingProstatic NeoplasmsAgedHumansMaleProstate-Specific AntigenRetrospective StudiesTreatment OutcomeUltrasonographyProstate-Specific Antigencomplications [Subheading]High-Intensity Focused Ultrasound AblationProstate cancer, familial [Supplementary Concept]

Identifiers

PMID32822127
PMCPMC7527093
OpenAlexW3080080703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.